Stay updated on PF-06463922 ALK/ROS1 Inhibitor Clinical Trial

Sign up to get notified when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.2.0 to v3.3.2 with no changes to study data or content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T13:43:16.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the generic government funding/operational status notice from the page header; the study history and data remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T07:22:24.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The Record History page shows updates only in its version list; no new content sections were added or removed.
    Difference
    0.1%
    Check dated 2025-11-03T21:21:09.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    7%
    Check dated 2025-10-06T05:57:07.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-29T03:12:46.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2, indicating a new release. The 'Back to Top' element was removed, a minor navigation change with no evident impact on core content.
    Difference
    0.4%
    Check dated 2025-09-14T19:54:18.000Z thumbnail image

Stay in the know with updates to PF-06463922 ALK/ROS1 Inhibitor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.